Related Experiment Video
Updated: Aug 13, 2026

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
Published on: August 2, 2017
What makes our brain unique: Insights from a two-night fMRI-EEG sleep study
Fan Nils Yang1, Dante Picchioni1, Jacco A de Zwart1
1Advanced MRI Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
None:
Functional connectomes (FCs) derived from fMRI are unique to an individual and can be reliably distinguished from those of others. However, the neurobiological basis for this "fingerprint"-like uniqueness remains unclear. One hypothesis holds that FC fingerprinting reflects idiosyncratic conscious experiences, while an alternative suggests that stable, intrinsic brain functional network structure underpins individual specificity. To test these hypotheses, we analyzed FC fingerprints across sleep stages using a two-night concurrent EEG-fMRI dataset from healthy participants and exploited the natural fluctuations in consciousness that occur across the sleep-wake cycle: during sleep, consciousness gradually diminishes from N1 to N3 non-REM (NREM) sleep, then partially reemerges during REM sleep. Contrary to the consciousness-dependent hypothesis, we found that FC fingerprinting remained robust, and in fact improved during deep, unconscious sleep (N3) relative to wakefulness. Moreover, the brain networks contributing most to individual identification shifted across sleep stages, with hippocampal connectivity playing a larger role during N3. Finally, using a deep-learning classifier (multi-layer perceptron) on short (90 seconds) fMRI segments, we demonstrated high identification accuracy; notably, models trained on deep-sleep data generalized well across all stages, including wakefulness. These findings favor the view that individual-specific network architecture rather than moment-to-moment conscious experience underlies FC fingerprints, with important implications for their use as biomarkers in both healthy and clinical populations.
